Reposted by Biagio Ricciuti, MD PhD
FDA approves durvalumab for adults with limited-stage small cell #LungCancer (LS-SCLC) who have not progressed after concurrent platinum-based chemotherapy and radiation. Efficacy was demonstrated in the ADRIATIC trial
buff.ly/3OCSXfz
@stephenvliu.bsky.social
@biagioricciutimd.bsky.social
